Results 51 to 60 of about 13,665 (250)
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Malignant histiocytosis associated with malabsorption
The Turkish Journal of Pediatrics, 1979 G Hiçsönmez, M Cağlar, F Ersoy
doaj +2 more sources
Rosai-Dorfman Disease- A Surprise diagnosis in Follow up of SCC Pyriform Sinus -Post Surgery and CTRT [PDF]
National Journal of Laboratory Medicine, 2013 Rosai-Dorfman disease also known as Sinus Histiocytosis with massive Lymphadenopathy (SHML). SHML was first described by Rosai and Dorfman in 1969 [1] and is now considered a non malignant inflammatory disorder in which the precise origin of ...
Nandeesh M, Anitha T.K., Santosh R.
doaj +1 more source
Differential Diagnoses of Systemic Mastocytosis in Routinely Processed Bone Marrow Biopsy Specimens: A Review [PDF]
, 2010 Diagnosis of systemic mastocytosis (SM) is mainly based on the morphological demonstration of compact mast cell infiltrates in various tissue sites. In almost all patients such infiltrates are detected in the bone marrow.
Horny, H. -P., Sotlar, K., Valent, P.
core +1 more source
International Journal of Cancer, EarlyView.What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. [PDF]
, 2015 Langerhans cell histiocytosis (LCH) is a rare disease caused by the clonal accumulation of dendritic Langerhans cells, which is often accompanied by osteolytic lesions.
Acha-Orbea, H. +11 more
core +10 more sources
Intracranial Rosai-Dorfman Disease: pathophysiology, diagnosis and treatment
Journal of Education, Health and Sport, 2022 Introduction and purpose: Rosai-Dorfman Disease (RDD), known also as sinus histiocytosis with massive lymphadenopathy(SHML) is a benign histiocytic proliferative syndrome. The etiology and pathogenesis of RDD remains unclear.
Michał Szymoniuk +3 more
doaj +1 more source
International Journal of Osteoarchaeology, EarlyView.ABSTRACT This study aims to identify lesions confined to the internal structures of bones. A radiographic analysis was performed on 219 archaeological, historical period skeletons from southern Finland. Although the study examines nearly all preserved skeletal elements using plain radiographs, it does not incorporate computed tomography.
Kati Salo +2 more
wiley +1 more source
BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. [PDF]
, 2015 BACKGROUND: Langerhans cell histiocytosis (LCH) is characterized by the proliferation of pathologic Langerhans cells. The disease can develop in any age and can affect almost any organ. Cutaneous involvement is frequent in LCH.
Badalian-Very +18 more
core +1 more source
Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations [PDF]
, 2011 Epstein-Barr virus (EBV) is a highly successful herpesvirus, colonizing more than 90% of the adult human population worldwide, although it is also associated with various malignant diseases.
Fox, Christopher P +2 more
core +2 more sources